← Back to catalogue

Belotero Volume (+) Lidocaine

FDA PMA

Class III (US FDA PMA)

PMA P250020

by Merz North America, Inc.

Identity

Trade Name
Belotero Volume (+) Lidocaine FDA PMA
Generic Name
Implant, dermal, for aesthetic use FDA PMA

Identifiers

PMA Number
P250020 FDA PMA
FDA Product Code
LMH FDA PMA

Classification

Device Class
Class III FDA PMA
Advisory Committee
General, Plastic Surgery FDA PMA
FDA Decision
APPR Approved FDA PMA

Belotero Volume (+) Lidocaine is a dermal implant classified as an implant for aesthetic use, designed to correct volume deficits or contour deficiencies in the mid-face region. It is composed of hyaluronic acid with lidocaine, intended for deep (subcutaneous or supraperiosteal) injection to restore volume and improve facial contours in adults aged 22 and older.

This device is supplied as a sterile, single-use injectable gel and is regulated under FDA Premarket Approval (PMA). It is administered in a clinical setting by trained professionals, adhering to sterile techniques. The product is available in pre-filled syringes and is intended for aesthetic procedures only, with no indication for therapeutic use. Authorisation is granted under PMA number P250020.

Frequently asked questions

What is Belotero Volume (+) Lidocaine used for in clinical practice?

Belotero Volume (+) Lidocaine is specifically authorized for deep injection (subcutaneous or supraperiosteal) to restore volume or correct contour deficiencies in the mid-face region of adults aged 22 and older. It is designed exclusively for aesthetic purposes, meaning it is not intended for therapeutic or medical treatments beyond improving facial contours.

How is Belotero Volume (+) Lidocaine supplied, and is it reusable?

Belotero Volume (+) Lidocaine is supplied as a sterile, single-use injectable gel in pre-filled syringes. Due to its sterile nature and single-use classification, it must not be reused or repackaged for multiple administrations.

What regulatory pathway does Belotero Volume (+) Lidocaine follow, and who can administer it?

Belotero Volume (+) Lidocaine is regulated under the FDA’s Premarket Approval (PMA) pathway, with approval granted under PMA number P250020. It is intended for administration by trained professionals in a clinical setting, adhering to strict sterile techniques.

Are there multiple sizes or models of Belotero Volume (+) Lidocaine available?

The provided data does not specify exact volume sizes or model variations beyond its classification as a dermal implant for aesthetic use. However, the product is supplied in pre-filled syringes, which typically vary in volume for different clinical needs. For precise sizing options, refer to the manufacturer’s packaging or technical documentation.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Belotero® Hyaluronfiller - Faltenbehandlung & Volumen, Belotero® - Behandlung, Kosten, Risiken | info Medizin, Belotero – Volumen und Konturen wiederherstellen | MorySkin, Belotero® - Merz Aesthetics, Belotero Soft Lidocaine | Hyaluronsäure-Filler für Volumenaufbau ...

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA PMA P250020 23 fields · synced Sep 18, 2026